header bg

Novel Coronavirus (2019-nCoV) or COVID-19

2019

2018

2017

2016

Novel Coronavirus (2019-nCoV) or COVID-19

Technical Services Bulletin
Novel Coronavirus (2019-nCoV) or COVID-19

Symptoms are mostly ‘cold’ like, usually mild to moderate cough, headache, sore throat and fever. In more serious cases symptoms include pneumonia and bronchitis.

Prevention and control recommendations from the CDC include 1) Minimize chances of exposure, 2) Adherence to standard precautions 3) Manage visitor access and movement, 4) Implement Engineering controls, 5) Monitor and manage ill and exposed health personnel, 6) Train and educate health personnel, 7) Implement environmental Infection Control.

This bulletin is not intended to provide guidance on the Novel Coronavirus (2019-nCoV). For current guidance and information please refer to the Centers for Disease Control and Prevention(CDC) site:
https://www.cdc.gov/coronavirus/2019-ncov/index.html

RGF-BioControls® for Hospitals and Healthcare

Air purification and isolation room systems designed to reduce the risk of infectious airborne pathogen transmission. All Microcon® products are FDA 510(k) and CDC compliant.

Microcon® MAP: Mobile HEPA Air Purifier removes hazardous airborne microbial contaminants using a unique ‘Circumflow’ air pattern to greatly improve ‘breathing zone’ air filtration.
https://www.rgf.com/products/biocontrols/microcon-400-800-map/

Microcon® ExC7: Self contained, ceiling mounted HEPA filter module used for creating negative or positive isolation room pressure. Quickly and easily installed into existing and new facilities with Ecophan® blower module and Accustat® room pressure monitor to create fully automated, compliant Airborne Infection Isolation Rooms.
https://www.rgf.com/products/biocontrols/microcon-exc7-exc7-uv/

Isoport™: Customizable, modular negative pressure isolation rooms easily assembled onsite to encapsulate infectious patients while aerosolized medications are administered.
https://www.rgf.com/products/biocontrols/isoport/

In-Duct Air Purification

PHI-Cell® QRP Guardian Air: UV based advanced oxidation technology installed in the HVAC ductwork to neutralize airborne pollutants like bacteria, virus, odor and mold. Third party testing on H1N1 and Avian Influenza demonstrate inactivation rates of 99+% within 6 hours.*
https://www.rgf.com/product-category/air/commercial-industrial/

Microcon® and PHI-Cell® are proven effective systems allowing for easy customization, quick installation, and provide the freedom and flexibility in planning for infection control and patient loading. For more information visit www.rgf.com or to speak with our RGF-BioControls® healthcare support team call 1-800-842-771 or email biocontrols@rgf.com

*Disclaimer: PHI-Cell® QRP has not been tested on coronavirus and is not a medical device therefore no medical claims are made. Testing conducted by independent accredited labs and university.

Contact RGF-BioControls®: biocontrols@rgf.com / 1-800-842-7771 / www.rgf.com/rgf-biocontrols
RGF-BioControls® is a division of RGF Environmental Group, Inc.

View this bulletin in PDF

MENU